Please login to the form below

Not currently logged in
Email:
Password:

Takeda files US patent case

Takeda sues Dr Reddy's over patent infringements related to Dexilant drug

Takeda Pharmaceutical has filed a patent infringement suit against India's Dr Reddy's Laboratories in a New York court. The suit relates to efforts from Dr Reddy's to manufacture a generic version of Takeda's acid reflux treatment drug Dexilant (dexlansoprazole).

Takeda alleges that the Indian generic-drug maker and its US subsidiary have infringed US patent numbers through the submission of an abbreviated new drug application seeking approval to market generic versions of Dexilent.

The drug has an annual market size of more than $300m in the US market, according to IMS Health figures.

Dr Reddy's was unavailable for comment at the time of writing.

13th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics